| Previous Close | 35.45 |
| Open | 35.93 |
| Bid | 35.85 x 400 |
| Ask | 35.86 x 1400 |
| Day's Range | 35.82 - 36.21 |
| 52 Week Range | 29.83 - 36.21 |
| Volume | 4,388,844 |
| Avg. Volume | 17,372,446 |
| Market Cap | 213.21B |
| Beta | 1.06 |
| PE Ratio (TTM) | 26.23 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.62%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
- The Wall Street Journal•3 minutes ago
[$$] Pfizer Files Lawsuit Alleging J&J Thwarted Use of Biosimilar Rival to Remicade
Pfizer filed suit against Johnson & Johnson alleging it has thwarted biosimilar competition to its arthritis drug Remicade by effectively preventing health insurers, hospitals and clinics from offering ...
- MarketWatch•7 minutes ago
Pfizer's stock jumps to 13-month high to lead Dow gainers after analyst upgrade
Shares of Pfizer Inc. surged 1.3% in morning trade Wednesday toward a 13-month high, after the drug maker was upgraded at Morgan Stanley, which cited valuation following "a long period of middling ...
Reuters•14 minutes agoPfizer sues Johnson & Johnson over Remicade biosimilar
Pfizer Inc on Wednesday filed a lawsuit against Johnson & Johnson , saying that the drugmaker's anticompetitive contracts with health insurers prevented biosimilar competition to its blockbuster rheumatoid ...
